Editas Medicine, Inc. (EDIT) EDIT-301 Program Update: RUBY and EdiTHAL Trials Data Update (Transcript)

Editas Medicine, Inc. (NASDAQ:EDIT) EDIT-301 Program Update: RUBY and EdiTHAL Trials Data Update December 11, 2023 1:00 PM ET Company Participants Cristi Barnett - Corporate Communications & IR Gilmore O'Neill - CEO Baisong Mei - CMO Caren Deardorf - Chief Commercial & Strategy Officer Conference Call Participants Jack Allen - Baird Gena Wang - Barclays Joon Lee - Truist Securities Samantha Semenkow - Citigroup Yanan Zhu - Wells Fargo Luca Issi - RBC Capital Markets Phil Nadeau - TD Cowen Dae Gon Ha - Stife ...